Conference Header
Conference Header

AUCD: Concurrent Sessions: Group 4: Value Assessments and their potential for discrimination


pptx File PIPC AUCD Panel.pptx [download]


Sara van Geertruyden, BA, JD, Executive Director
Partnership to Improve Patient Care


Metrics for measuring ?cost effectiveness? or value of treatments often relies on discriminatory methods, like the quality-adjusted-life-year (QALY), which values the lives of people with disabilities as worth less than non-disabled people. Value assessment is increasingly at the center of state and federal discussions about drug pricing. This panel gives an overview of value assessments, their potential for discrimination, and related public policy threats at the federal and state level.

Back to Session: Concurrent Sessions: Group 4